The stock price of Bioceres Crop Solutions Corp (NASDAQ: BIOX) has plunged by -1.00% when compared to previous closing price of $4.99, but the company has seen a 4.22% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-06-20 that ROSARIO, Argentina–(BUSINESS WIRE)–Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, today announced changes to the composition of its Board of Directors. Noah Kolatch and Scott Crocco are being appointed to the Company’s Board of Directors with effect from June 24, 2025. Noah Kolatch is a Principal at Jaspe.
Is It Worth Investing in Bioceres Crop Solutions Corp (NASDAQ: BIOX) Right Now?
The stock has a 36-month beta value of 0.45. Opinions on the stock are mixed, with 4 analysts rating it as a “buy”, 0 as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for BIOX is 36.76M, and at present, short sellers hold a 1.86% of that float. On July 04, 2025, the average trading volume of BIOX was 130.16K shares.
BIOX’s Market Performance
BIOX’s stock has seen a 4.22% increase for the week, with a -1.20% drop in the past month and a 10.02% gain in the past quarter. The volatility ratio for the week is 7.26%, and the volatility levels for the past 30 days are at 6.18% for Bioceres Crop Solutions Corp The simple moving average for the past 20 days is 5.25% for BIOX’s stock, with a -14.17% simple moving average for the past 200 days.
Analysts’ Opinion of BIOX
Many brokerage firms have already submitted their reports for BIOX stocks, with Canaccord Genuity repeating the rating for BIOX by listing it as a “Buy”. The predicted price for BIOX in the upcoming period, according to Canaccord Genuity is $17 based on the research report published on July 19, 2024 of the previous year 2024.
ROTH MKM, on the other hand, stated in their research note that they expect to see BIOX reach a price target of $15. The rating they have provided for BIOX stocks is “Buy” according to the report published on July 02nd, 2024.
Canaccord Genuity gave a rating of “Buy” to BIOX, setting the target price at $22.50 in the report published on September 30th of the previous year.
BIOX Trading at 6.99% from the 50-Day Moving Average
After a stumble in the market that brought BIOX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.06% of loss for the given period.
Volatility was left at 6.18%, however, over the last 30 days, the volatility rate increased by 7.26%, as shares surge +0.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +15.42% upper at present.
During the last 5 trading sessions, BIOX rose by +4.22%, which changed the moving average for the period of 200-days by -42.29% in comparison to the 20-day moving average, which settled at $4.69. In addition, Bioceres Crop Solutions Corp saw -55.62% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
N/A, the N/A of Bioceres Crop Solutions Corp, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for BIOX
Current profitability levels for the company are sitting at:
- 0.05% for the present operating margin
- 0.4% for the gross margin
The net margin for Bioceres Crop Solutions Corp stands at -0.02%. The total capital return value is set at 0.04%. Equity return is now at value -3.00%, with -1.11% for asset returns.
Based on Bioceres Crop Solutions Corp (BIOX), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.13. The debt to equity ratio resting at 0.89. The interest coverage ratio of the stock is 0.77.
Currently, EBITDA for the company is 55.45 million with net debt to EBITDA at 6.85. When we switch over and look at the enterprise to sales, we see a ratio of 1.42. The receivables turnover for the company is 1.93for trailing twelve months and the total asset turnover is 0.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.02.
Conclusion
To sum up, Bioceres Crop Solutions Corp (BIOX) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
